About this trial
This study aims to investigate the relationship between hypertension and obstructive sleep apnea (OSA) using heart rate variability (HRV) as a non-invasive biomarker of autonomic nervous system function.
Hypertensive patients at high risk for OSA will undergo 24-hour Holter electrocardiogram monitoring to assess HRV parameters, along with overnight polysomnography (PSG) to determine OSA severity. The study will analyze the association between HRV indices and the apnea-hypopnea index (AHI), and develop predictive models using machine learning techniques.
In addition, patients diagnosed with OSA will be followed after treatment, and changes in HRV and blood pressure will be evaluated to assess treatment effects and autonomic function recovery.
The results of this study may provide a cost-effective and clinically applicable approach for early detection, risk stratification, and management of OSA in patients with hypertension.
Eligibility criteria
Qualifiers
Age 18 to 65 years
Diagnosed hypertension or resistant hypertension
STOP-Bang score ≥3 indicating high risk of obstructive sleep apnea
Willing and able to provide informed consent
Disqualifiers
Refusal to undergo HRV monitoring or polysomnography
Unstable medical condition that may interfere with study participation
Inability to comply with study procedures
Trial design
Treatments tested in this trial
- Polysomnography